Pityriasis amiantaceahttps://en.wikipedia.org/wiki/Pityriasis_amiantacea
Pityriasis amiantacea bụ ọnọdụ eczematous nke akpụkpọ isi, nke na-eme ka akpụkpọ ahụ sie ike ma nwee mkpuchi siri ike. Ọ naghị ebute ọnya ma ọ bụ alopecia n'ọtụtụ ọnọdụ.

Pityriasis amiantacea na-emetụta isi, na-eme ka akpụkpọ isi nwee mkpuchi siri ike, na-acha ọcha ma ọ bụ na-acha ọbara ọbara. Akpụkpọ ahụ gbara gburugburu ma na-ekekọta ntutu isi. Enwere ike ịkọwa ọnọdụ a ma ọ bụ kpuchie isi ya niile. Alopecia nwa oge na alopecia na-afụ ụfụ nwere ike ime n'ihi iwepụ ntutu isi ugboro ugboro. Ọ bụ ọrịa na-adịghị ahụkebe.

○ Ọgwụgwọ ― OTC Ọgwụ
* Ngwa keratolytic nwere urea nwere ike inye aka belata mkpuchi siri ike.
#40% urea cream

* Jiri ncha ntutu isi na-egbochi ọfụfụ kwa ụbọchị.
#Ciclopirox shampoo
#Ketoconazole shampoo
#Fluocinolone shampoo
#Pyrithione zinc shampoo
#Selenium sulfide shampoo

* Tinye ọgwụ steroid OTC naanị n'akụkụ ebe ọfụfụ na-apụta. Mara na itinye nnukwu steroid n'isi nwere ike ibute folliculitis.
#Hydrocortisone cream
☆ AI Dermatology — Free Service
Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
      References Pityriasis amiantacea - Case reports 25506575 
      NIH
      Otu nwata nwoke dị afọ iri na anọ nwere akpịrịkpa gbara agba na-acha odo odo n'isi ya, karịsịa n'ihu na n'elu. Ebe ndị ahụ metụtara na-acha uhie uhie na akpụkpọ anụ, nwere ntutu isi ma ọ nweghị ọnyà. Nlele maka ero dị njọ.
      A 14-year-old male patient presented with focal masses of thick, adherent, plate like, yellow-brown scales, attached to the hair shafts, predominantly affecting the fronto-parietal area and vertex of the scalp. The underlying scalp had thick, erythematous plaques with fine, non greasy, silvery-white scaling with noncicatricial alopecia. Potassium hydroxide examination of scales and hair and culture for fungus was negative.
       Pityriasis amiantacea: a study of seven cases 27828657 
      NIH
      The disease may be secondary to any skin condition that primarily affects the scalp, including seborrheic dermatitis. Its pathogenesis remains uncertain. We aim to analyze the epidemiological and clinical profiles of patients with pityriasis amiantacea to better understand treatment responses. We identified seven cases of pityriasis amiantacea and a female predominance in a sample of 63 pediatric patients with seborrheic dermatitis followed for an average of 20.4 months. We reported a mean age of 5.9 years. Five patients were female, with a mean age of 9 years. All patients were successfully treated with topic ketoconazole.